Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
(130 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
{{TOCright}}
 
{{TOCright}}
−
:Co-chairs: Gregory Goldmacher, MD, PhD, MBA; Jenifer Siegelman, MD, MPH; Ehsan Samei, PhD
+
:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
−
:Secretary: Julie Lisiecki
+
:RSNA Staff Support: Julie Lisiecki
−
:Roster: [[Media:QIBA CT Volumetry Roster.pdf|(Roster)]]
+
* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
 +
* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
  
 
==Meetings==
 
==Meetings==
−
* Tcons are held roughly Weekly. Contact the secretary for details.
+
* Tcons are held periodically. Contact RSNA Staff for details.
−
* [[Call Summaries]]
+
 
−
:*[[Lung Nodule Assessment in CT Screening Call Summary Archive]]
+
 
 +
'''Recent Call Summaries:'''
 +
*[[Media:06 17 2021 QIBA CT Volumetry BC Call-FINAL.pdf|06.17.2021 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:05 06 2021 QIBA CT Volumetry BC Call-FINAL.pdf|05.06.2021 QIBA CT Volumetry BC Call Summary]]
 +
 
 +
*[[Media:07 23 2020 QIBA CT Volumetry BC Call-FINAL.pdf|07.23.2020 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:06 02 2020 QIBA CT Volumetry TF Call-FINAL.pdf|06.02.2020 QIBA CT Volumetry TF Call Summary]]
 +
*[[Media:04 30 2020 QIBA CT Volumetry Tf Call-FINAL.pdf|04.30.2020 QIBA CT Volumetry TF Call Summary]]
 +
*[[Media:03 12 2020 QIBA CT Volumetry BC Call-FINAL.pdf|03.12.2020 QIBA CT Volumetry Call Summary]]
 +
 
 +
'''''[[CT Volumetry BC Call Summaries Archive]]'''''
  
 
==Profile Development==
 
==Profile Development==
Line 13: Line 24:
 
===Advanced Disease/Tumor Volume Change Profile===
 
===Advanced Disease/Tumor Volume Change Profile===
  
−
Status - Consensus Profile complete
+
'''Status - Technical Confirmation in Ballot'''
−
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf | QIBA Profile: CT Tumor Volume Change Profile]] ''CONSENSUS 2016.11.21b''
+
 
−
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]] ''Field Trial v1.0''
+
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_DraftTechConfirmed-20180511-changetracked.docx | CT Tumor Volume Change Profile - Change tracked]] ''BALLOT DRAFT 2018.05.11''
 +
** This document shows all changes between the published Consensus Profile and the Ballot for Technically Confirmed.
  
−
Technical Confirmation in progress
 
−
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_PostConsensus-20170403.docx | CT Tumor Volume Change Profile - PostConsensus]] ''DRAFT 2017.04.03''
 
−
:* [[Invitation to Participate]] - Feasibility Testing
 
−
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0_DUKE+Notes2017.02.27.pdf | Duke feasibility results with committee notes]] 2017.02.27
 
−
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-RUMC+Notes-20170306.docx| Rush feasibility results with committee notes]] 2017.03.06
 
−
:* Columbia Volume repeatability assessment - Coming Soon
 
−
::* [[Media:QIBA_CT_Volumetry_Field_Test_ACR_Phantom_Scan_Protocol.pdf| Columbia Scan Protocol]]
 
  
 
Past and Future
 
Past and Future
−
:* [[Archived Versions#Advanced_disease|Archived Versions]] of QIBA draft CT Volumetry Profile-related documents.
+
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
 
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
−
 
−
===Lung Nodule Assessment in CT Screening===
 
−
Status - Public Comment complete; now resolving comments into Consensus Profile
 
−
 
−
*[[Media:QIBA CT Vol Tumor Volume Change, 02.05.2014-2.doc|QIBA Profile: CT Volumetry: Lung Nodule Volume Assessment and Monitoring in Lung Cancer Screening, 02.05.2014'']] '5February2014' 
 
−
 
−
:*[[Archive for Lung Nodule Assessment in CT Screening Draft Profiles]]
 
  
 
==Groundwork Projects==
 
==Groundwork Projects==
Line 49: Line 47:
 
==Reference Materials==
 
==Reference Materials==
  
−
===2012===
+
'''2012'''
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
 
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
−
===2011===
+
'''2011'''
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
Line 60: Line 58:
 
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
 
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
  
−
===2010===
+
'''2010'''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
 
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
Line 72: Line 70:
 
*[[Archive - Initial Target Selection and Roadmap]]
 
*[[Archive - Initial Target Selection and Roadmap]]
  
−
==Round 1 of QIBA Funded Projects==
+
==QIBA Funded Projects==
  
 +
'''Round 1'''
 
*[[Duke University]]
 
*[[Duke University]]
 
*[[Columbia University Medical Center]]
 
*[[Columbia University Medical Center]]
Line 80: Line 79:
 
*[[CoreLab Partners, Inc.]]
 
*[[CoreLab Partners, Inc.]]
  
−
==Round 2 of QIBA Funded Projects==
+
'''Round 2'''
−
 
 
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 +
 +
'''Round 3'''
 +
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf | Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
 +
 +
'''Round 4'''
 +
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf | Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
 +
 +
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf | Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
 +
 +
'''Round 5'''
 +
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf | Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
 +
 +
'''Round 6'''
 +
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf | Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]

Revision as of 14:06, 17 June 2021

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
RSNA Staff Support: Julie Lisiecki

Meetings

  • Tcons are held periodically. Contact RSNA Staff for details.


Recent Call Summaries:

CT Volumetry BC Call Summaries Archive

Profile Development

Advanced Disease/Tumor Volume Change Profile

Status - Technical Confirmation in Ballot


Past and Future

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6

Retrieved from "https://qibawiki.rsna.org/index.php?title=CT_Volumetry_Biomarker_Ctte&oldid=16927"